Press Release
October 02, 2020
Icon Genetics clinical development of its novel norovirus vaccine reaches milestone of complete dosing of the first cohort
continue reading
Press Release
September 23, 2020
DENKA press release: Phase I Clinical Study to Develop a Norovirus Vaccine Commenced in Belgium
continue reading
Press Release
March 11, 2020
A new investment in Sachsen-Anhalt is announced to build a pilot facility to support healthcare related research & development and the manufacturing of proteins for diagnostic use.
continue reading
Press Release
August 23, 2017
Denka Completes the Acquisition of Icon Genetics GmbH, a German Bio-Pharmaceutical R&D Company, Making It a Wholly Owned Subsidiary
continue reading
Press Release
August 07, 2015
Announcement of Acquisition of Shares (Ownership) in Icon Genetics GmbH, a German Bio-pharmaceutical R&D Company
continue reading
Press Release
January 31, 2014
Icon Genetics successfully completes Phase I clinical study with personalized vaccines for treatment of non-Hodgkin’s lymphoma
continue reading
Press Release
December 17, 2013
Icon Genetics and Bayer CropScience successfully completed the development of a plant host system with designer glycosylation needed for manufacturing biopharmaceuticals in green plants
continue reading
Press Release
November 01, 2012
Icon Genetics’ personalized vaccine clinical trials is featured in documentary series from Baylor Health Care System
continue reading
Press Release
September 20, 2012
Icon Genetics to Provide John Innes Centre Access to Golden Gate Cloning Platform
continue reading